Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Drug Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover how this novel asymmetric catalytic hydrogenation method enables high-yield, high-ee synthesis of chiral dihydro-9-phenanthrene amine for pharmaceutical applications.